Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Thrombosis × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Terminated 3 Completed 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 41 Carcinoma, Non-Small-Cell Lung 25 Colorectal Neoplasms 16 Neoplasms 14 Stomach Neoplasms 10 Rectal Neoplasms 10 Nasopharyngeal Carcinoma 10 Lung Neoplasms 10 Leukemia, Myeloid, Acute 10 Carcinoma, Hepatocellular 10 Squamous Cell Carcinoma of Head and Neck 8 Small Cell Lung Carcinoma 8 Esophageal Neoplasms 8 Prostatic Neoplasms 7 Multiple Myeloma 7 Recurrence 6 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Neoplasm Metastasis 5 Glioblastoma 5 Colonic Neoplasms 5 Carcinoma, Renal Cell 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Polycystic Ovary Syndrome 4 Leukemia, Lymphocytic, Chronic, B-Cell 4

Interventions

enoxaparin sodium 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡